Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
MUSTANG BIO, INC. (MBIO)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/04/2023 |
8-K
| Other Events Interactive Data |
08/16/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
08/14/2023 |
8-K
| Quarterly results |
07/31/2023 |
8-K
| Quarterly results |
07/20/2023 |
8-K
| Quarterly results |
07/11/2023 |
8-K
| Termination of a Material Definitive Agreement Interactive Data |
06/30/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
05/12/2023 |
8-K
| Quarterly results |
04/20/2023 |
8-K
| Quarterly results |
04/03/2023 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
03/29/2023 |
8-K
| Quarterly results |
12/13/2022 |
8-K
| Quarterly results |
11/25/2022 |
8-K
| Quarterly results |
11/14/2022 |
8-K
| Quarterly results |
08/11/2022 |
8-K
| Quarterly results |
07/07/2022 |
8-K
| Quarterly results |
06/24/2022 |
8-K
| Quarterly results |
05/31/2022 |
8-K
| Quarterly results |
05/12/2022 |
8-K
| Quarterly results |
04/22/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
03/23/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
03/17/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
03/08/2022 |
8-K
| Quarterly results |
11/12/2021 |
8-K
| Quarterly results
Docs:
|
"MUSTANG BIO, INC. Condensed Balance Sheets September 30, December 31, 2021 2020 ASSETS Current Assets: Cash and cash equivalents $ 120,879 $ 97,804 Other receivables - related party 41 15 Prepaid expenses and other current assets 1,028 1,715 Total current assets 121,948 99,534 Property, plant and equipment, net 9,418 7,529 Fixed assets - construction in process 1,019 499 Restricted cash 1,000 1,000 Other assets 254 250 Operating lease right-of-use asset, net 1,067 1,088 Total Assets $ 134,706 $ 109,900 LIABILITIES AND STOCKHOLDERS’ EQUITY Current Liabilities: Accounts payable and accrued expenses $ 9,834 $ 8,747 Payables and accrued expenses - related party 296 490 Operating lease liabilities - short-term 329 278 Total current liabilities 10,459 9,515 Deferred income 270 — Operating lease ..." |
|
09/28/2021 |
8-K
| Quarterly results |
09/24/2021 |
8-K
| Quarterly results |
08/16/2021 |
8-K
| Quarterly results
Docs:
|
"MUSTANG BIO, INC. Condensed Balance Sheets June 30, December 31, 2021 2020 ASSETS Current Assets: Cash and cash equivalents $ 129,923 $ 97,804 Other receivables - related party 32 15 Prepaid expenses and other current assets 1,386 1,715 Total current assets 131,341 99,534 Property, plant and equipment, net 7,155 7,529 Fixed assets - construction in process 2,355 499 Restricted cash 1,000 1,000 Other assets 255 250 Operating lease right-of-use asset, net 1,101 1,088 Total Assets $ 143,207 $ 109,900 LIABILITIES AND STOCKHOLDERS’ EQUITY Current Liabilities: Accounts payable and accrued expenses $ 5,766 $ 8,747 Payables and accrued expenses - related party 249 490 Operating lease liabilities - short-term 346 278 Total current liabilities 6,361 9,515 Operating lease liabilities - long-term 1,82..." |
|
06/22/2021 |
8-K
| Quarterly results |
05/14/2021 |
8-K
| Quarterly results |
03/24/2021 |
8-K
| Quarterly results |
12/31/2020 |
8-K
| Quarterly results |
12/04/2020 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ...
Docs:
|
"CERTIFICATE OF AMENDMENT OF THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MUSTANG BIO, INC. Mustang Bio, Inc. , a corporation organized and existing under and by virtue of the Delaware General Corporation Law , does hereby certify: 1. The Amended and Restated Certificate of Incorporation of the Corporation, as amended, is hereby amended by deleting the first sentence of Article IV, Section A thereof in its entirety and inserting the following in lieu thereof: “The total number of shares of all classes of capital stock that the Corporation shall have the authority to issue is one hundred twenty-five million shares of Common Stock, with $0.0001 par value, of which one million shares are designated as “Class A Common Stock” and the remainder are undesignated Common Stock, and two m..." |
|
11/06/2020 |
8-K
| Quarterly results
Docs:
|
"MUSTANG BIO, INC. Condensed Balance Sheets September 30, December 31, 2020 2019 ASSETS Current Assets: Cash and cash equivalents $ 75,251 $ 61,413 Other receivables - related party 37 19 Prepaid expenses and other current assets 344 1,631 Total current assets 75,632 63,063 Property, plant and equipment, net 7,250 6,779 Fixed assets - construction in process 821 1,157 Restricted cash 1,000 1,000 Other assets 250 250 Operating lease right-of-use asset, net 1,115 1,196 Total Assets $ 86,068 $ 73,445 LIABILITIES AND STOCKHOLDERS’ EQUITY Current Liabilities: Short-term notes payable $ — $ 1,250 Accounts payable and accrued expenses 7,054 5,668 Payables and accrued expenses - related party 305 596 Operating lease liabilities - short-term 271 257 Total current liabilities 7,630 7,771 Notes payabl..." |
|
10/05/2020 |
8-K
| Quarterly results |
|
|
|